Cargando…
931. Host PFKFB3-dependent glycolytic reprogramming as a broad-spectrum antiviral strategy
BACKGROUND: The current therapeutic arsenal against viral infections remains poor, with limited spectrum of coverage and appears inadequate to face the emergence of pandemic and antiviral resistance. This study aims to develop a broad-spectrum antiviral strategy for rapid epidemic control and early...
Autores principales: | Yuan, Shuofeng, Ye, Zi-Wei, Chu, Hin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677171/ http://dx.doi.org/10.1093/ofid/ofad500.976 |
Ejemplares similares
-
SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target
por: Yuan, Shuofeng, et al.
Publicado: (2019) -
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
por: Liu, Jia, et al.
Publicado: (2020) -
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)
por: Yuan, Shuofeng, et al.
Publicado: (2020) -
PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
por: Dou, Qianhui, et al.
Publicado: (2022) -
Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target
por: Yuan, Shuofeng, et al.
Publicado: (2020)